Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NOS2 | P35228 | 2/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2153739 | 0.87 | ALDH1A1 (0.55) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL11701754 | 0.86 | SKP2 (0.62) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL11559770 | 0.85 | ALDH1A1 (0.46) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL29611441 | 0.85 | SKP2 (0.39) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL16337442 | 0.82 | PTGS2 (0.53) | ALDH1A1TP53CYP3A4SKP2KDM4E | |
| SCHEMBL19480452 | 0.82 | PTGS2 (0.53) | ALDH1A1TP53CYP3A4SKP2KDM4E | |
| SCHEMBL18830614 | 0.82 | PTGS2 (0.53) | ALDH1A1TP53CYP3A4SKP2KDM4E | |
| SCHEMBL13984313 | 0.80 | TAAR1 (0.50) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL5610598 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TP53CYP3A4TSHRTDP1 | |
| SCHEMBL28131083 | 0.79 | FFAR4 (0.47) | ALDH1A1CYP3A4SKP2FFAR4HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117624221-A | Aza-binuclear large-volume anionic-cationic complex, and preparation method and application thereof | 中化学科学技术研究有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-111133032-B | Polyimide, polyimide varnish, and polyimide film | 三菱瓦斯化学株式会社 | 2022-07-19 | — | — | CN | disclosed |
| CN-111051384-B | Polyimide, polyimide varnish, and polyimide film | 三菱瓦斯化学株式会社 | 2022-06-28 | — | — | CN | disclosed |
| CN-108884245-B | Polyimide film and method for producing same | 柯尼卡美能达株式会社 | 2021-10-29 | — | — | CN | disclosed |
| CN-109563280-B | Polyimide resin film and method for producing polyimide resin film | 三菱瓦斯化学株式会社 | 2021-10-15 | — | — | CN | disclosed |
| CN-109843534-B | Method for manufacturing optical film | 柯尼卡美能达株式会社 | 2021-05-18 | — | — | CN | disclosed |
| CN-109843533-B | Method for manufacturing optical film | 柯尼卡美能达株式会社 | 2021-05-04 | — | — | CN | disclosed |
| WO-2020195819-A1 | METHOD FOR MANUFACTURING OPTICAL FILM AND OPTICAL FILM | コニカミノルタ株式会社 | 2020-10-01 | — | — | WO | disclosed |
| CN-111183194-A | Polyimide varnish composition, method for producing same, and polyimide film | 三菱瓦斯化学株式会社 | 2020-05-19 | — | — | CN | disclosed |
| CN-111133032-A | Polyimide, polyimide varnish, and polyimide film | 三菱瓦斯化学株式会社 | 2020-05-08 | — | — | CN | disclosed |
| US-20030114472-A1 | Viricides | JANSSEN PHARMACEUTICA, N.V. (BE) | 2003-06-19 | — | — | US | disclosed |
| EP-1002795-B1 | HIV Replication inhibiting pyrimidines | JANSSEN PHARMACEUTICA NV (BE) | 2003-03-05 | — | — | EP | disclosed |
| EP-1282607-A2 | PRODRUGS OF HIV REPLICATION INHIBITING PYRIMIDINES | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-02-12 | — | — | EP | disclosed |
| EP-1270560-A1 | Hiv replication inhibiting pyrimidines | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-01-02 | — | — | EP | disclosed |
| EP-1225874-A1 | ANTIVIRAL COMPOSITIONS | Janssen Pharmaceutica N.V. (BE) | 2002-07-31 | — | — | EP | disclosed |
| WO-2001085699-A2 | PRODRUGS OF HIV REPLICATION INHIBITING PYRIMIDINES | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001022938-A1 | ANTIVIRAL COMPOSITIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-04-05 | — | — | WO | disclosed |
| EP-1002795-A1 | HIV Replication inhibiting pyrimidines | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-05-24 | — | — | EP | disclosed |
| WO-2000027825-A1 | HIV REPLICATION INHIBITING PYRIMIDINES | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-05-18 | — | — | WO | disclosed |
| US-4147804-A | ANTIARRHYTHMIA AGENTS | WILLIAM H. RORER, INC. (US) | 1979-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114472-A1 | Viricides | ZC3HAV1, ZC3HAV1L, POLR2H | ALDH1A1 2470/4885TP53 1542/4885CYP3A4 1164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.